GlassScriptPhysician profile
Howard Rosas
NPI 1285785147
$2,902.20
in general payments reported to CMS, 2019-2025
16 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2021: $257 · 2022: $678 · 2023: $941 · 2024: $512 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $517.29 | 2021-2025 | Krystexxa |
| Abbott Laboratories | $337.05 | 2019-2023 | Diamondback Peripheral |
| Paratek Pharmaceuticals, INC. | $265.41 | 2023-2024 | Nuzyra |
| Averitas Pharma INC. | $255.00 | 2023-2024 | Qutenza |
| Horizon Therapeutics Plc | $248.71 | 2022-2023 | Krystexxa |
| Smith+Nephew, INC. | $173.74 | 2019-2023 | Acticoat 4" X 4", Iodosorb Ointment 40g USA, Collagenase Santyl |
| Nevro Corp. | $144.17 | 2022 | |
| Treace Medical Concepts, INC. | $135.47 | 2022 | |
| Misonix INC | $131.94 | 2021 | |
| Polynovo North America LLC | $127.13 | 2024 | Novosorb Btm |
| Leo Pharma INC. | $125.04 | 2023 | Adbry |
| Ibsa Pharma INC. | $125.00 | 2023 | Licart |
| Angiodynamics, INC. | $118.00 | 2022 | |
| Medtronic Vascular, INC. | $86.31 | 2019 | |
| Orthofix Medical, INC. | $65.00 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $46.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Rosas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.